I

    Inventiva Sa (IVA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.68
    -0.02 (-0.53%)

    Market Cap: $1.11B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    48%(10/21)
    Avg Surprise
    -45.55%
    Streak
    2 Q

    Upcoming Estimates

    Jun 30, 2026
    EPS Consensus$-0.20
    Range$-0.20 - $-0.20
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.20+0.0%
    60d ago$-0.20+0.0%
    30d ago$-0.20+0.0%
    7d ago$-0.20+0.0%
    Current$-0.20
    Revenue Consensus
    $3M
    Range$0 - $6M
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26EST
    		-$-0.20---
    Mar 26
    		$0.00N/A+100.00%Beat+100.0%
    Dec 25
    		$0.00N/A+100.00%Beat+100.0%
    Sep 25
    		$-0.30$-0.29-3.45%Miss+60.5%
    Jun 25
    		$-1.62$-0.60-167.86%Miss-85.9%
    Mar 25
    		$-2.00$-0.43-365.12%Miss-316.7%
    Dec 24
    		$-1.82$-0.43-323.26%Miss-183.8%
    Sep 24
    		$-0.76$-0.56-35.71%Miss+22.4%
    Jun 24
    		$-0.87$-0.63-37.74%Miss+37.3%
    Mar 24
    		$-0.48$-0.47-2.13%Miss-65.5%
    Dec 23
    		$-0.64$-0.40-60.30%Miss-132.5%
    Sep 23
    		$-0.98$-0.98+0.00%Beat-
    Jun 23
    		$-1.39$-1.39+0.00%Beat-
    Mar 23
    		$-0.29$-0.29+0.00%Beat-
    Dec 22
    		$-0.28$0.08-444.75%Miss-72.4%
    Sep 22
    		$0.00$0.00N/ABeat-
    Jun 22
    		$0.00$0.00N/ABeat-
    Mar 22
    		$0.00$0.00N/ABeat+100.0%
    Dec 21
    		$-0.16N/A+66.67%Beat+66.6%
    Sep 21
    		$0.00N/A+100.00%Beat+100.0%
    Jun 21
    		$0.00N/A+100.00%Beat+100.0%
    Mar 21
    		$-0.44$-0.33-32.33%Miss-62.4%
    Dec 20
    		$-0.48$-0.48+0.00%Beat-16.8%
    Sep 20
    		$-0.39$-0.38-3.94%Miss+62.7%
    Jun 20
    		$-0.21N/A+53.33%Beat-
    Mar 20
    		$-0.27$0.00N/AMiss+70.2%
    Dec 19
    		$-0.41N/AN/ABeat+58.9%
    Jun 19
    		$-1.05N/AN/ABeat-58.1%
    Mar 19
    		$0.00$0.00N/ABeat+100.0%
    Dec 18
    		$-0.91N/AN/ABeat-192.3%
    Jun 18
    		$-1.00N/AN/ABeat-
    Dec 17
    		$-0.67N/AN/ABeat-
    Jun 17
    		$-0.76N/AN/ABeat-
    Dec 16
    		$-0.31N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.82EV/EBITDA-1.35x
    Price/FCF-12.90xFCF Yield-7.75%
    Profitability
    Profit Margin0.00%Operating Margin-6711.00%
    ROE-1643.00%ROIC-15591.97%
    Financial Health
    Debt/Equity-1.10xInterest Coverage-6.39x
    Current Ratio3.15xQuick Ratio3.15x
    Trading Statistics
    Beta0.91Avg Volume660.47K
    52-Week High$7.9852-Week Low$3.35

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.72
    SMA 20$4.70
    SMA 50$4.40
    SMA 200$5.06
    EMA 10$4.72
    EMA 20$4.67
    EMA 50$4.59
    EMA 200$4.78

    MACD

    Line: 0.07Signal: 0.08Hist: -0.01

    ADX

    ADX: 13.1+DI: 20.6-DI: 22.3

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down24.0
    PSAR$4.47

    Bollinger Bands

    Upper Band$4.87
    Lower Band$4.53
    %B Position721%(Upper)
    Band Width0.45

    RSI (14-Day)

    Neutral
    51.9

    Momentum Oscillators

    Stoch %K58.8
    Stoch %D66.0
    Williams %R-56.6
    ROC (10d)-0.4%
    Momentum-0.02
    CCI (20d)-52.4
    MFI (14d)41.0

    Volatility Measures

    ATR (14d)$0.21(4.5%)
    StdDev (20d)0.08
    Hist Vol39.1%(Moderate)

    Volume Flow

    VWAP$4.64
    OBV12.0M
    AD Line10.1M
    CMF (20d)0.063

    Volume Metrics

    Avg Vol (20d)643.2K
    Vol Ratio1.6x(High)
    VWMA (20d)$4.70

    Pivot Points

    R3$5.03
    R2$4.93
    R1$4.82
    Pivot Point$4.72
    S1$4.61
    S2$4.51
    S3$4.40

    Advanced Oscillators

    TSI11.05
    Ultimate Osc54.0
    KST69.54

    Financial Data

    QuarterMar 2026Dec 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Jun 2023Mar 2023Dec 2022
    Total Revenue$28,785$28,785$4.45M$6.46M$6.46M$2.73M$2.73M$16.54M$16.54M$6.62MN/A$15.42M
    Cost of Revenue$1.20M$1.20M$1.70M$-526,000$-526,000$526,000N/A$558,000$558,000$459,000N/A$474,000
    Gross Profit$-1,169,280$-1,169,280$2.75M$6.99M$6.99M$2.21M$2.73M$15.98M$15.98M$6.16MN/A$14.95M
    Operating Expenses$77.77M$77.77M$59.55M$52.30M$52.30M$54.46M$54.98M$63.69M$63.69M$60.06MN/A$39.42M
    R&D$42.96M$42.96M$43.31M$44.06M$44.06M$46.82M$46.82M$55.95M$55.95M$54.06M$0$30.60M
    SG&A$0$33.17M$15.88M$7.57M$8.92M$7.14M$7.70M$6.54M$6.54M$6.34M$0$5.69M
    Operating Income$-74,144,540$-74,144,540$-56,802,000$-45,309,000$-45,309,000$-52,249,000$-52,249,000$-47,706,000$-47,706,000$-55,001,000N/A$-23,619,000
    Interest Income$0$0$0$0$1.14M$0$0$0$0$0$0$0
    Interest Expense$23.70M$23.70M$9.74M$12.18M$12.18M$5.69M$0$3.21M$6.84M$1.96M$0$507,000
    Income Before Tax$-164,816,166$-164,816,166$-177,510,000$-134,991,000$-134,991,000$-48,910,000$-48,910,000$-54,543,000$-54,543,000$-55,276,000$0$-24,809,000
    Income Tax Expense$-621,365$-621,365$-1,628,000$194,000$194,000$119,000$119,000$614,000$614,000$-7,000$-3,500$-1,000
    Net Income$-176,936,545$-176,936,545$-175,882,000$-135,183,000$-135,183,000$-49,029,000$-49,029,000$-55,157,000$-55,157,000$-55,269,000N/A$-24,808,000
    EBITDA$-77,738,288$-77,738,288$-165,841,000$-114,707,000$-114,707,000$-51,818,000$-51,818,000$-46,248,000$-47,985,000$-53,863,000N/A$-23,384,000
    EBIT$-78,936,353$-78,936,353$-167,545,000$-119,474,000$-119,474,000$-52,249,000$-52,249,000$-47,709,000$-47,709,000$-55,001,000$-27,500,500$-23,619,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about IVA

    News

    Full Year 2025 Inventiva SA Earnings Call Transcript

    Inventiva SA held its Full Year 2025 earnings call, highlighting the completion of enrollment for its Phase III NATIV-3 trial for lanifibranor and strong financial stability with €230.9 million in cash. While the company has strengthened its leadership and secured breakthrough therapy designation for lanifibranor, the top-line readout for NATIV-3 has been delayed to Q4 2026, and competition in the MASH market is increasing. The company's future funding is contingent on positive NATIV-3 results.

    GuruFocus•8/24/26•
    Neutral

    Inventiva SA (XTER:6IV) Stock Forecast, Price Targets and Analysts Predictions

    This article provides a stock forecast and analyst predictions for Inventiva SA (XTER:6IV). It includes current market data such as stock price, market cap, and enterprise value, alongside GuruFocus's proprietary GF Score. The article also mentions sections for detailed price targets, analyst ratings, forecast summaries, and growth forecasts, which are available upon subscription.

    GuruFocus•8/24/26•
    Neutral

    Inventiva SA (XTER:6IV) Stock Price & 30 Year Financial Data

    This article provides a 30-year financial overview for Inventiva SA (XTER:6IV), including key growth rates for revenue, EPS, EBIT, EBITDA, and Free Cash Flow. It details the company's market capitalization and enterprise value, noting that PE and PB ratios are currently zero. The data presentation explains how growth rates are calculated and offers options for viewing and exporting financial information.

    GuruFocus•8/23/26•
    Neutral

    Inventiva Stock Operating Data

    This GuruFocus.com page provides operating data for Inventiva SA (XTER:6IV), a biotechnology company. Key financial metrics include a market cap of €949.66M, an enterprise value of €778.65M, and indicates that the company is currently operating at a loss with a P/E ratio of 0. The article also notes seven severe warning signs detected by GuruFocus for 6IV.

    GuruFocus•8/23/26•
    Somewhat-Bearish

    IVA Price History for Inventiva S.A. ADR Stock

    This article provides an overview of the IVA (Inventiva S.A. ADR) stock price history on Barchart.com. It details the available historical data, including daily prices, latest trades, and corporate actions, accessible to different membership tiers. The article also highlights key performance indicators such as 52-week highs and lows and Fibonacci levels.

    Barchart.com•8/14/26•
    Neutral

    Frequently Asked Questions About IVA

    Does IVA pay dividends?
    Inventiva Sa (IVA) does not currently pay a regular dividend.
    What is IVA's market cap?
    Inventiva Sa (IVA) has a market capitalization of $1.11B with a current stock price of $4.68.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In